Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Innovent and HUTCHMED Jointly Announce NDA Acceptance in China for Sintilimab Combination with Fruquintinib for the Treatment of Advanced Endometrial Cancer with Priority Review Status 2024-04-02 13:00
Fosun International: Total Revenue for 2023 Reached RMB198.2 billion, Industrial Operation Profit Increased by 20% YoY 2024-04-02 11:31
Kemwell BioPharma Drives Quality Excellence with Veeva Vault QMS 2024-04-02 10:30
Oncoclínicas&Co has revenues of R$6 billion and profit of R$313 million in 2023 2024-04-02 00:38
ThinkCyte advances biopharma phenotypic drug discovery programs with publication and presentation milestones 2024-04-01 21:00
Lunit to Showcase 7 Studies at AACR 2024: Unveiling AI Innovations in HER2 Expression-Mutation Analysis and CNTN4 Biomarker Identification 2024-04-01 21:00
Novel Immunogenicity Risk Assessment Platform, ISPRI, Facilitates Biologic Therapeutics Development 2024-04-01 20:00
Aculys Pharma Announces Appointment of Hidemasa Tanigaki as New CEO 2024-04-01 14:30
Hyosung TNC Invests $1 Billion in Future "Bio" Business 2024-04-01 08:18
LISCure Biosciences receives U.S. FDA Fast Track designation for LB-P8 for the treatment of primary sclerosing cholangitis (PSC) 2024-03-29 21:00
73% CNS ORR! FDA Granted ODD to Utidelone Injectable (UTD1) from Biostar Pharma for the Treatment of Breast Cancer Brain Metastasis 2024-03-29 20:40
Alebund's Innovative Investigational Drug AP303 Receives FDA Orphan Drug Designation (ODD) for the Treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD) 2024-03-29 20:00
IASO Bio Announces NMPA's IND Approval for Equecabtagene Autoleucel in Second- and Third-Line Treatment of Multiple Myeloma 2024-03-29 17:20
Alphamab Oncology Reports Full Year 2023 Financial Results and Business Highlights 2024-03-29 10:42
Jacobio Pharma Announces 2023 Annual Results 2024-03-29 08:50
Bridge Biotherapeutics Launches a Research Collaboration with Emory University School of Medicine to Explore Combination Therapy of BBT-877 for KRAS/P53 Mutant NSCLC Patients Resistant to Anti-PD-1 Blockade 2024-03-29 06:00
Viva Biotech (1873.HK) Announces 2023 Annual Results: Successful Implementation of Light-asset Strategy, Achieving Solid Growth and Promising Future 2024-03-28 22:46
Broncus Medical (02216.HK) Announces Annual Results for 2023 2024-03-28 22:32
Harbour BioMed Reports Full Year 2023 Financial Results 2024-03-28 22:10
GenFleet and BeiGene Enter into Trial Collaboration for a Potentially First-in-class Combination Therapy to Initiate Phase Ib/II Study of GFH009 (CDK9 inhibitor) and BRUKINSA® (zanubrutinib) Treating Diffuse Large B Cell Lymphoma 2024-03-28 19:00
1 44 45 46 47 48 451